Official UK procurement notice
Recombinant Quadrivalent Influenza Vaccine (Supemtek)
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought
Published requirement descriptionThis procurement is for the supply of recombinant quadrivalent influenza vaccine (Supemtek) to NHSScotland for use in the annual seasonal influenza immunisation programme.
CPV: Influenza vaccines
The lotProcurement structure
single lot · no lot value publishedLot #1This procurement is for the supply of recombinant quadrivalent influenza vaccine…Awarded
This procurement is for the supply of recombinant quadrivalent influenza vaccine (Supemtek) for use in the annual seasonal influenza immunisation programme.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 13 Aug 2021, 14:55 BST
- Last source update
- 8 Oct 2021, 10:24 BST
- Authority reference
NP93821d- FTS notice number
2021/S 000-025158- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02d49aFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Aventis Pharma t/a Sanofi are currently the only supplier of recombinant quadrivalent influenza vaccine (Supemtek) for which no direct competition exists.
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts(Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The total value in Sections II.1.7 and V.2.4 refers to the eight (8) month duration of the Contract. (SC Ref:665554)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Aventis Pharma Ltd Trading As Sanofi | £2,257,600 †same award published again · counted once | — | Awarded |
| Aventis Pharma Ltd Trading As Sanofi | £2,257,600 † | — | Awarded |
Contracts
Contract 025158-2021-NP93821d-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 30 Aug 2021
- Value
- £2,257,600
- Status
- active
Contract 019755-2021-NP93821d-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 13 Aug 2021
- Value
- £2,257,600
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Bidders & participating suppliers
1 commercial party on the notice- Aventis Pharma Ltd t/a SanofiAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.